05/12/2008 Michael J. Fox on Access Hollywood
In an exclusive two-part interview, Michael J. Fox talked to "Access Hollywood" about Parkinson's disease, the Foundation's progress, and his excitement to be back in Los Angeles surrounded by friends supporting the Foundation at "Playing to Win the Fight against Parkinson's," a poker tournament benefit held at Social Hollywood.
05/09/2008 Read Katie Hood's Blog on The Huffington Post
MJFF CEO Katie Hood launched her Huffington Post blog with a post on the need for an "American Center for Cures" to align the efforts of disparate parties to speed cures for Parkinson's and all disease.
04/28/2008 14th Annual Parkinson's Unity Walk Raises Funds, Awareness for Parkinson's Research
The 14th annual Parkinson's Unity Walk, held in New York City's Central Park on Saturday, April 26, 2008, brought together over 10,000 members of the Parkinson's community to raise funds and awareness for Parkinson's research.
04/28/2008 'Agitation and Idealism' -- Read Katie Hood's Comments from the 14th Annual Parkinson's Unity Walk
Read a transcript of remarks given by Katie Hood, MJFF CEO, at the 14th Annual Parkinson's Unity Walk held in New York City's Central Park on Saturday, April 26, 2008.
04/24/2008 Four Questions For: Marlene Kahan, Executive Director, ASME
Mediabistro.com's FishbowlNY blog spoke with Marlene Kahan, PWP and executive director of the American Society of Magazine Editors (ASME), about the sense of purpose she feels raising awareness of Parkinson's, and whether she thinks the magazine industry does enough for staffers battling diseases like hers.
The Michael J. Fox Foundation announced a $5.6-million award to drive a Phase 2 clinical trial to investigate the potential of inosine — a naturally occurring chemical that gives rise to urate in the body — to slow or stop the progression of Parkinson’s disease.
04/07/2008 Registration Open for Annual PD Therapeutics Conference
The Michael J. Fox Foundation has opened registration for its annual PD Therapeutics Conference to be held in Chicago, Illinois, on September 15, 2008.
The Michael J. Fox Foundation for Parkinson’s Research seeks applications for its $10-million 2008 Therapeutics Development Initiative. The 2008 program includes a special funding track for academic researchers.
03/25/2008 Michael J. Fox Foundation Commits Up to $2 Million to Improve Drug Delivery for Parkinson's Disease
The Michael J. Fox Foundation for Parkinson’s Research announced the launch of a new funding program, Improving Delivery of Parkinson’s Disease Therapeutics to the Brain.
The Foundation has announced a $1-million new Web-based Clinical Assessment Program to drive the creation and testing of Web-based tools that would allow any patient with a personal computer and an Internet connection to participate in clinical research from the comfort of their own home.
The Michael J. Fox Foundation for Parkinson’s Research would like to bring to your attention the following meeting: 2008 AAPS Workshop on Demonstrating Disease Modifying Effects for the Treatment of Parkinson’s Disease: Drug Development and Regulatory Issues.
Michael J. Fox Foundation for Parkinson’s Research today announced the 2008 launch of its annual Clinical Intervention Awards.
02/13/2008 Save the Date: Research Roundtable in Ft. Lauderdale, Florida, on March 25
The Michael J. Fox Foundation invites you to attend a Research Roundtable presentation titled "The MJFF Funding Philosophy and Research Portfolio Highlights."
Four industry research projects targeted as part of innovative Therapeutics Development Initiative.
Approximately $2 million in total funding was awarded to seven research studies aiming to advance the ability of the Parkinson’s research field, and drug makers, to therapeutically target two genes — LRRK2 and alpha-synuclein.
Founding gift for “The Grove Circle,” honoring planned gift donors,
reflects shared commitment to transformative approach
01/10/2008 Save the Date: Research Roundtable in Menlo Park, California, on January 15
The Michael J. Fox Foundation invites you to attend a Research Roundtable presentation titled "MJFF Strategic Overview: The Michael J. Fox Foundation's Philosophy and Role in Funding Translational Research for Parkinson's Therapies."
A research team funded under the Foundation's LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) initiative will work to optimize a small interfering RNA (siRNA)-based therapeutic that could slow or stop the progression of Parkinson’s disease by reducing expression of the protein alpha-synuclein.
